Morgan Stanley
-
-
-
-
-
-
-
UPDATE: Morgan Stanley Upgrades BioMarin Pharmaceutical Inc. (BMRN) to Overweight
-
-
-
-
-
-
-
BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $120 at Morgan Stanley
-
-
-
-
-
-
-
Notable Analyst Rating Changes 12/8: (JNPR) (HES) (COR) Upgraded; (FIT) (AZZ) (ARCX) Downgraded
-
-
-
-
-
-
-
Pre-Open Stock Movers 06/01: (DWRE) (GALE) (KORS) Higher; (APHB) (UA) (NKE) Lower (more...)
-
-
-
-
-
-
-
Pre-Open Stock Movers 03/27: (OLN) (OREX) (BMRN) (DOW) Higher; (OHRP) (APDN) (RH) Lower (more...)
-
-
-
-
-
-
-
Pre-Open Stock Movers 11/24: (RNA) (CIMT) (PTP) Higher; (LGF) (TSL) (CBI) Lower (more...)
-
-
-
-
-
-
-
Notable Analyst Rating Changes 11/06: (UBS) (CMG) (AIV) Upgraded; (ESRX) (BMRN) (TWTC) Downgraded
-
224,955 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

